Exploring Public Sentiment on the Repurposing of Ivermectin for COVID-19 Treatment: Cross-Sectional Study Using Twitter Data

被引：0

作者：

Kautsar, Angga Prawira ^{[1
,2
,3
]}

Sinuraya, Rano Kurnia ^{[1
,3
,4
]}

van der Schans, Jurjen ^{[1
,5
]}

Postma, Maarten Jacobus ^{[1
,3
,5
]}

Suwantika, Auliya A. ^{[3
,4
,6
]}

机构：

[1] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Unit Global Hlth, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands

[2] Univ Padjadjaran, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Sumedang, Indonesia

[3] Univ Padjadjaran, Ctr Excellence Higher Educ Pharmaceut Care Innovat, Bandung, Indonesia

[4] Univ Padjadjaran, Fac Pharm, Dept Pharmacol & Clin Pharm, Sumedang, Indonesia

[5] Univ Groningen, Fac Econ & Business, Dept Econ Econometr & Finance, Groningen, Netherlands

[6] Univ Padjadjaran, Ctr Hlth Technol Assessment, Bandung, Indonesia

来源：

JMIR FORMATIVE RESEARCH | 2025年 / 9卷

关键词：

COVID-19; ivermectin; sentiment analysis; Twitter; social media; public health; misinformation; geolocation analysis;

D O I：

10.2196/50536

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

A sentiment analysis of 5051 Twitter posts fromJanuary 2022 found that 53.4% of them expressed positive views on ivermectin as a COVID-19 treatment, 35.6% of them were neutral, and 11% of them were negative, highlighting the polarized public perception and the need for careful interpretation of social media data in health communication.

引用

页数：4

共 10 条

[1]

[Anonymous], Why You Should Not Use Ivermectin to Treat or Prevent COVID-19

[2] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].